Annual Income Statements for Lineage
This table shows Lineage's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Lineage
This table shows Lineage's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
| Metric |
|
Q2 2023 |
Q3 2023 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
| Net Income / (Loss) Attributable to Common Shareholders |
|
-5.00 |
-39 |
-68 |
-485 |
0.00 |
| Consolidated Net Income / (Loss) |
|
-8.00 |
-50 |
-80 |
-543 |
0.00 |
| Net Income / (Loss) Continuing Operations |
|
-8.00 |
-50 |
-80 |
-543 |
0.00 |
| Total Pre-Tax Income |
|
-8.00 |
-55 |
-73 |
-588 |
8.00 |
| Total Revenue |
|
-3.00 |
-5.00 |
2.00 |
8.00 |
16 |
| Net Interest Income / (Expense) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Interest Income |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Non-Interest Income |
|
-3.00 |
-5.00 |
2.00 |
8.00 |
16 |
| Net Realized & Unrealized Capital Gains on Investments |
|
-3.00 |
-5.00 |
2.00 |
8.00 |
16 |
| Total Non-Interest Expense |
|
-111 |
-97 |
-74 |
515 |
-56 |
| Other Operating Expenses |
|
1,029 |
1,021 |
1,018 |
1,040 |
1,030 |
| Depreciation Expense |
|
136 |
137 |
164 |
156 |
158 |
| Amortization Expense |
|
52 |
51 |
55 |
54 |
54 |
| Impairment Charge |
|
3.00 |
4.00 |
15 |
8.00 |
-21 |
| Restructuring Charge |
|
15 |
19 |
12 |
592 |
15 |
| Other Special Charges |
|
-1,346 |
-1,329 |
-1,338 |
-1,335 |
-1,292 |
| Nonoperating Income / (Expense), net |
|
-116 |
-147 |
-149 |
-81 |
-64 |
| Income Tax Expense |
|
0.00 |
-5.00 |
7.00 |
-45 |
8.00 |
| Net Income / (Loss) Attributable to Noncontrolling Interest |
|
-3.00 |
-11 |
-12 |
-58 |
0.00 |
| Basic Earnings per Share |
|
($0.08) |
($0.26) |
($0.46) |
($2.44) |
$0.01 |
| Weighted Average Basic Shares Outstanding |
|
162M |
162M |
162M |
210M |
228M |
| Diluted Earnings per Share |
|
($0.08) |
($0.26) |
($0.46) |
($2.44) |
$0.01 |
| Weighted Average Diluted Shares Outstanding |
|
162M |
162M |
162M |
210M |
228M |
| Weighted Average Basic & Diluted Shares Outstanding |
|
- |
- |
227.69M |
228.41M |
228.59M |
Annual Cash Flow Statements for Lineage
This table details how cash moves in and out of Lineage's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
| Metric |
2022 |
2023 |
2024 |
| Net Change in Cash & Equivalents |
-38 |
-131 |
104 |
| Net Cash From Operating Activities |
501 |
796 |
703 |
| Net Cash From Continuing Operating Activities |
501 |
796 |
703 |
| Net Income / (Loss) Continuing Operations |
-76 |
-96 |
-751 |
| Consolidated Net Income / (Loss) |
-76 |
-96 |
-751 |
| Provision For Loan Losses |
5.00 |
6.00 |
5.00 |
| Depreciation Expense |
678 |
760 |
876 |
| Amortization Expense |
17 |
21 |
19 |
| Non-Cash Adjustments to Reconcile Net Income |
2.00 |
3.00 |
609 |
| Changes in Operating Assets and Liabilities, net |
-125 |
102 |
-55 |
| Net Cash From Investing Activities |
-2,369 |
-1,066 |
-919 |
| Net Cash From Continuing Investing Activities |
-2,369 |
-1,066 |
-919 |
| Purchase of Property, Leasehold Improvements and Equipment |
-813 |
-766 |
-691 |
| Purchase of Investment Securities |
-1,652 |
-319 |
-355 |
| Sale and/or Maturity of Investments |
3.00 |
19 |
127 |
| Net Cash From Financing Activities |
1,840 |
136 |
320 |
| Net Cash From Continuing Financing Activities |
1,829 |
136 |
320 |
| Issuance of Debt |
3,411 |
1,431 |
6,593 |
| Issuance of Common Equity |
0.00 |
-6.00 |
4,879 |
| Repayment of Debt |
-2,255 |
-1,312 |
-10,624 |
| Repurchase of Common Equity |
0.00 |
-12 |
-42 |
| Payment of Dividends |
-191 |
-46 |
-234 |
| Other Financing Activities, Net |
864 |
81 |
-252 |
| Effect of Exchange Rate Changes |
-10 |
3.00 |
0.00 |
| Cash Interest Paid |
354 |
594 |
523 |
| Cash Income Taxes Paid |
74 |
31 |
36 |
Quarterly Cash Flow Statements for Lineage
This table details how cash moves in and out of Lineage's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2023 |
Q4 2023 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
| Net Change in Cash & Equivalents |
|
-29 |
-41 |
336 |
-237 |
22 |
| Net Cash From Operating Activities |
|
229 |
231 |
186 |
257 |
139 |
| Net Cash From Continuing Operating Activities |
|
229 |
231 |
186 |
257 |
139 |
| Net Income / (Loss) Continuing Operations |
|
-50 |
-57 |
-543 |
-80 |
0.00 |
| Consolidated Net Income / (Loss) |
|
-50 |
-57 |
-543 |
-80 |
0.00 |
| Provision For Loan Losses |
|
2.00 |
2.00 |
1.00 |
2.00 |
1.00 |
| Depreciation Expense |
|
188 |
203 |
210 |
236 |
212 |
| Amortization Expense |
|
5.00 |
5.00 |
4.00 |
3.00 |
2.00 |
| Non-Cash Adjustments to Reconcile Net Income |
|
21 |
-3.00 |
493 |
97 |
24 |
| Changes in Operating Assets and Liabilities, net |
|
63 |
81 |
21 |
-1.00 |
-100 |
| Net Cash From Investing Activities |
|
-191 |
-421 |
-138 |
-383 |
-138 |
| Net Cash From Continuing Investing Activities |
|
-191 |
-421 |
-138 |
-383 |
-138 |
| Purchase of Property, Leasehold Improvements and Equipment |
|
-177 |
-161 |
-153 |
-205 |
-151 |
| Acquisitions |
|
- |
-1.00 |
3.00 |
- |
0.00 |
| Purchase of Investment Securities |
|
-38 |
-265 |
-39 |
-246 |
-6.00 |
| Sale and/or Maturity of Investments |
|
24 |
6.00 |
51 |
71 |
19 |
| Net Cash From Financing Activities |
|
-64 |
146 |
284 |
-108 |
21 |
| Net Cash From Continuing Financing Activities |
|
-64 |
146 |
284 |
-108 |
21 |
| Issuance of Debt |
|
346 |
606 |
1,446 |
308 |
582 |
| Repayment of Debt |
|
-395 |
-427 |
-5,883 |
-273 |
-423 |
| Repurchase of Common Equity |
|
- |
-9.00 |
- |
-17 |
0.00 |
| Payment of Dividends |
|
- |
-46 |
- |
-145 |
-134 |
| Other Financing Activities, Net |
|
127 |
28 |
-158 |
19 |
-4.00 |
| Effect of Exchange Rate Changes |
|
-3.00 |
3.00 |
4.00 |
-3.00 |
0.00 |
| Cash Interest Paid |
|
163 |
148 |
135 |
69 |
86 |
| Cash Income Taxes Paid |
|
-10 |
-1.00 |
2.00 |
6.00 |
1.00 |
Annual Balance Sheets for Lineage
This table presents Lineage's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
2023 |
2024 |
| Total Assets |
18,871 |
18,661 |
| Cash and Due from Banks |
68 |
173 |
| Restricted Cash |
3.00 |
2.00 |
| Trading Account Securities |
113 |
124 |
| Loans and Leases, Net of Allowance |
0.00 |
0.00 |
| Premises and Equipment, Net |
10,571 |
10,627 |
| Goodwill |
3,394 |
3,338 |
| Intangible Assets |
1,280 |
1,127 |
| Other Assets |
3,442 |
3,270 |
| Total Liabilities & Shareholders' Equity |
18,871 |
18,661 |
| Total Liabilities |
12,849 |
8,967 |
| Short-Term Debt |
134 |
190 |
| Other Short-Term Payables |
1,137 |
1,303 |
| Long-Term Debt |
10,263 |
6,155 |
| Other Long-Term Liabilities |
1,330 |
1,319 |
| Commitments & Contingencies |
0.00 |
0.00 |
| Redeemable Noncontrolling Interest |
349 |
43 |
| Total Equity & Noncontrolling Interests |
5,673 |
9,651 |
| Total Preferred & Common Equity |
5,051 |
8,638 |
| Preferred Stock |
1.00 |
0.00 |
| Total Common Equity |
5,050 |
8,638 |
| Common Stock |
5,963 |
10,766 |
| Retained Earnings |
-879 |
-1,855 |
| Accumulated Other Comprehensive Income / (Loss) |
-34 |
-273 |
| Noncontrolling Interest |
622 |
1,013 |
Quarterly Balance Sheets for Lineage
This table presents Lineage's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
Q2 2024 |
Q3 2024 |
Q1 2025 |
| Total Assets |
18,756 |
19,256 |
18,768 |
| Cash and Due from Banks |
73 |
409 |
197 |
| Trading Account Securities |
123 |
120 |
128 |
| Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
| Premises and Equipment, Net |
10,491 |
11,324 |
10,644 |
| Goodwill |
3,361 |
3,444 |
3,379 |
| Intangible Assets |
1,218 |
1,221 |
1,116 |
| Other Assets |
3,487 |
2,735 |
3,304 |
| Total Liabilities & Shareholders' Equity |
18,756 |
19,256 |
18,768 |
| Total Liabilities |
13,002 |
9,134 |
9,122 |
| Short-Term Debt |
50 |
136 |
189 |
| Other Short-Term Payables |
1,172 |
1,359 |
1,132 |
| Long-Term Debt |
10,593 |
4,955 |
5,130 |
| Other Long-Term Liabilities |
1,187 |
2,684 |
2,602 |
| Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
| Redeemable Noncontrolling Interest |
262 |
39 |
41 |
| Total Equity & Noncontrolling Interests |
5,492 |
10,083 |
9,605 |
| Total Preferred & Common Equity |
4,878 |
9,026 |
8,586 |
| Total Common Equity |
4,877 |
9,026 |
8,586 |
| Common Stock |
5,983 |
10,746 |
10,793 |
| Retained Earnings |
-987 |
-1,662 |
-1,976 |
| Accumulated Other Comprehensive Income / (Loss) |
-119 |
-58 |
-231 |
| Noncontrolling Interest |
614 |
1,057 |
1,019 |
Annual Metrics And Ratios for Lineage
This table displays calculated financial ratios and metrics derived from Lineage's official financial filings.
| Metric |
2022 |
2023 |
2024 |
| Growth Metrics |
- |
- |
- |
| Revenue Growth |
0.00% |
118.18% |
-1,150.00% |
| EBITDA Growth |
0.00% |
21.96% |
-58.41% |
| EBIT Growth |
0.00% |
46.18% |
-200.25% |
| NOPAT Growth |
0.00% |
46.18% |
-200.25% |
| Net Income Growth |
0.00% |
-26.32% |
-682.29% |
| EPS Growth |
0.00% |
-43.14% |
-406.85% |
| Operating Cash Flow Growth |
0.00% |
58.88% |
-11.68% |
| Free Cash Flow Firm Growth |
0.00% |
0.00% |
100.61% |
| Invested Capital Growth |
0.00% |
0.00% |
-2.31% |
| Revenue Q/Q Growth |
0.00% |
0.00% |
0.00% |
| EBITDA Q/Q Growth |
0.00% |
0.00% |
0.00% |
| EBIT Q/Q Growth |
0.00% |
0.00% |
0.00% |
| NOPAT Q/Q Growth |
0.00% |
0.00% |
0.00% |
| Net Income Q/Q Growth |
0.00% |
0.00% |
0.00% |
| EPS Q/Q Growth |
0.00% |
0.00% |
0.00% |
| Operating Cash Flow Q/Q Growth |
0.00% |
0.00% |
0.00% |
| Free Cash Flow Firm Q/Q Growth |
0.00% |
0.00% |
0.00% |
| Invested Capital Q/Q Growth |
0.00% |
0.00% |
0.00% |
| Profitability Metrics |
- |
- |
- |
| EBITDA Margin |
0.00% |
29,575.00% |
0.00% |
| EBIT Margin |
0.00% |
10,050.00% |
0.00% |
| Profit (Net Income) Margin |
0.00% |
-2,400.00% |
0.00% |
| Tax Burden Percent |
108.57% |
87.27% |
89.40% |
| Interest Burden Percent |
-25.45% |
-27.36% |
208.44% |
| Effective Tax Rate |
0.00% |
0.00% |
0.00% |
| Return on Invested Capital (ROIC) |
0.00% |
3.43% |
0.00% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
0.00% |
-3.83% |
0.00% |
| Return on Net Nonoperating Assets (RNNOA) |
0.00% |
-6.62% |
0.00% |
| Return on Equity (ROE) |
0.00% |
-3.19% |
-9.56% |
| Cash Return on Invested Capital (CROIC) |
0.00% |
-196.57% |
0.60% |
| Operating Return on Assets (OROA) |
0.00% |
2.13% |
0.00% |
| Return on Assets (ROA) |
0.00% |
-0.51% |
0.00% |
| Return on Common Equity (ROCE) |
0.00% |
-2.67% |
-8.32% |
| Return on Equity Simple (ROE_SIMPLE) |
0.00% |
-1.90% |
-8.69% |
| Net Operating Profit after Tax (NOPAT) |
193 |
281 |
-282 |
| NOPAT Margin |
0.00% |
7,035.00% |
0.00% |
| Net Nonoperating Expense Percent (NNEP) |
0.00% |
7.26% |
5.60% |
| SG&A Expenses to Revenue |
0.00% |
0.00% |
0.00% |
| Operating Expenses to Revenue |
0.00% |
-9,950.00% |
0.00% |
| Earnings before Interest and Taxes (EBIT) |
275 |
402 |
-403 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
970 |
1,183 |
492 |
| Valuation Ratios |
- |
- |
- |
| Price to Book Value (P/BV) |
0.00 |
0.88 |
1.55 |
| Price to Tangible Book Value (P/TBV) |
0.00 |
11.80 |
3.21 |
| Price to Revenue (P/Rev) |
0.00 |
1,109.20 |
0.00 |
| Price to Earnings (P/E) |
0.00 |
0.00 |
0.00 |
| Dividend Yield |
0.00% |
0.00% |
1.55% |
| Earnings Yield |
0.00% |
0.00% |
0.00% |
| Enterprise Value to Invested Capital (EV/IC) |
0.00 |
0.96 |
1.28 |
| Enterprise Value to Revenue (EV/Rev) |
0.00 |
3,933.70 |
0.00 |
| Enterprise Value to EBITDA (EV/EBITDA) |
0.00 |
13.30 |
41.88 |
| Enterprise Value to EBIT (EV/EBIT) |
0.00 |
39.14 |
0.00 |
| Enterprise Value to NOPAT (EV/NOPAT) |
0.00 |
55.92 |
0.00 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
0.00 |
19.77 |
29.31 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
0.00 |
0.00 |
210.46 |
| Leverage & Solvency |
- |
- |
- |
| Debt to Equity |
0.00 |
1.73 |
0.65 |
| Long-Term Debt to Equity |
0.00 |
1.70 |
0.63 |
| Financial Leverage |
0.00 |
1.73 |
1.07 |
| Leverage Ratio |
0.00 |
3.13 |
2.39 |
| Compound Leverage Factor |
0.00 |
-0.86 |
4.98 |
| Debt to Total Capital |
0.00% |
63.32% |
39.56% |
| Short-Term Debt to Total Capital |
0.00% |
0.82% |
1.18% |
| Long-Term Debt to Total Capital |
0.00% |
62.51% |
38.38% |
| Preferred Equity to Total Capital |
0.00% |
0.01% |
0.00% |
| Noncontrolling Interests to Total Capital |
0.00% |
5.91% |
6.58% |
| Common Equity to Total Capital |
0.00% |
30.76% |
53.86% |
| Debt to EBITDA |
0.00 |
8.79 |
12.90 |
| Net Debt to EBITDA |
0.00 |
8.73 |
12.54 |
| Long-Term Debt to EBITDA |
0.00 |
8.68 |
12.51 |
| Debt to NOPAT |
0.00 |
36.95 |
-22.49 |
| Net Debt to NOPAT |
0.00 |
36.70 |
-21.87 |
| Long-Term Debt to NOPAT |
0.00 |
36.47 |
-21.82 |
| Noncontrolling Interest Sharing Ratio |
0.00% |
16.14% |
12.90% |
| Liquidity Ratios |
- |
- |
- |
| Cash Flow Metrics |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
0.00 |
-16,138 |
98 |
| Operating Cash Flow to CapEx |
61.62% |
103.92% |
101.74% |
| Free Cash Flow to Firm to Interest Expense |
0.00 |
0.00 |
0.00 |
| Operating Cash Flow to Interest Expense |
0.00 |
0.00 |
0.00 |
| Operating Cash Flow Less CapEx to Interest Expense |
0.00 |
0.00 |
0.00 |
| Efficiency Ratios |
- |
- |
- |
| Asset Turnover |
0.00 |
0.00 |
0.00 |
| Fixed Asset Turnover |
0.00 |
0.00 |
0.00 |
| Capital & Investment Metrics |
- |
- |
- |
| Invested Capital |
0.00 |
16,419 |
16,039 |
| Invested Capital Turnover |
0.00 |
0.00 |
0.00 |
| Increase / (Decrease) in Invested Capital |
0.00 |
16,419 |
-380 |
| Enterprise Value (EV) |
0.00 |
15,735 |
20,604 |
| Market Capitalization |
4,437 |
4,437 |
13,378 |
| Book Value per Share |
$0.00 |
$31.17 |
$37.82 |
| Tangible Book Value per Share |
$0.00 |
$2.32 |
$18.27 |
| Total Capital |
0.00 |
16,419 |
16,039 |
| Total Debt |
0.00 |
10,397 |
6,345 |
| Total Long-Term Debt |
0.00 |
10,263 |
6,155 |
| Net Debt |
0.00 |
10,326 |
6,170 |
| Capital Expenditures (CapEx) |
813 |
766 |
691 |
| Net Nonoperating Expense (NNE) |
269 |
377 |
469 |
| Net Nonoperating Obligations (NNO) |
0.00 |
10,397 |
6,345 |
| Total Depreciation and Amortization (D&A) |
695 |
781 |
895 |
| Earnings Adjustments |
- |
- |
- |
| Adjusted Basic Earnings per Share |
$0.00 |
$0.00 |
($3.70) |
| Adjusted Weighted Average Basic Shares Outstanding |
0.00 |
0.00 |
191M |
| Adjusted Diluted Earnings per Share |
$0.00 |
$0.00 |
($3.70) |
| Adjusted Weighted Average Diluted Shares Outstanding |
0.00 |
0.00 |
191M |
| Adjusted Basic & Diluted Earnings per Share |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
0.00 |
0.00 |
228.20M |
| Normalized Net Operating Profit after Tax (NOPAT) |
-3,200 |
-3,394 |
-3,525 |
| Normalized NOPAT Margin |
0.00% |
-84,840.00% |
0.00% |
| Pre Tax Income Margin |
0.00% |
-2,750.00% |
0.00% |
| Debt Service Ratios |
- |
- |
- |
| EBIT to Interest Expense |
0.00 |
0.00 |
0.00 |
| NOPAT to Interest Expense |
0.00 |
0.00 |
0.00 |
| EBIT Less CapEx to Interest Expense |
0.00 |
0.00 |
0.00 |
| NOPAT Less CapEx to Interest Expense |
0.00 |
0.00 |
0.00 |
| Payout Ratios |
- |
- |
- |
| Dividend Payout Ratio |
-251.32% |
-47.92% |
-31.16% |
| Augmented Payout Ratio |
-251.32% |
-60.42% |
-36.75% |
Quarterly Metrics And Ratios for Lineage
This table displays calculated financial ratios and metrics derived from Lineage's official financial filings.
| Metric |
|
Q2 2023 |
Q3 2023 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
| Revenue Growth |
|
0.00% |
0.00% |
166.67% |
260.00% |
188.89% |
| EBITDA Growth |
|
0.00% |
0.00% |
-0.34% |
-202.81% |
-4.67% |
| EBIT Growth |
|
0.00% |
0.00% |
-29.63% |
-651.09% |
-13.25% |
| NOPAT Growth |
|
0.00% |
0.00% |
-29.63% |
-651.09% |
-100.00% |
| Net Income Growth |
|
0.00% |
0.00% |
-900.00% |
-986.00% |
100.00% |
| EPS Growth |
|
0.00% |
0.00% |
-475.00% |
-838.46% |
103.57% |
| Operating Cash Flow Growth |
|
0.00% |
0.00% |
0.00% |
-18.78% |
32.38% |
| Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Invested Capital Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Revenue Q/Q Growth |
|
0.00% |
-66.67% |
0.00% |
300.00% |
0.00% |
| EBITDA Q/Q Growth |
|
0.00% |
-3.72% |
0.00% |
-199.32% |
0.00% |
| EBIT Q/Q Growth |
|
0.00% |
-14.81% |
0.00% |
-767.11% |
0.00% |
| NOPAT Q/Q Growth |
|
0.00% |
-14.81% |
0.00% |
-767.11% |
0.00% |
| Net Income Q/Q Growth |
|
0.00% |
-525.00% |
0.00% |
-578.75% |
0.00% |
| EPS Q/Q Growth |
|
0.00% |
-225.00% |
0.00% |
-430.43% |
0.00% |
| Operating Cash Flow Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-45.91% |
| Free Cash Flow Firm Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
4.75% |
0.00% |
| Invested Capital Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-7.22% |
0.00% |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
| EBITDA Margin |
|
0.00% |
0.00% |
14,750.00% |
-3,662.50% |
1,787.50% |
| EBIT Margin |
|
0.00% |
0.00% |
3,800.00% |
-6,337.50% |
450.00% |
| Profit (Net Income) Margin |
|
0.00% |
0.00% |
-4,000.00% |
-6,787.50% |
0.00% |
| Tax Burden Percent |
|
100.00% |
90.91% |
109.59% |
92.35% |
0.00% |
| Interest Burden Percent |
|
-7.41% |
-59.78% |
-96.05% |
115.98% |
11.11% |
| Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
100.00% |
| Return on Invested Capital (ROIC) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Return on Net Nonoperating Assets (RNNOA) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Return on Equity (ROE) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-7.29% |
| Cash Return on Invested Capital (CROIC) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Operating Return on Assets (OROA) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Return on Assets (ROA) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Return on Common Equity (ROCE) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-6.49% |
| Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-8.19% |
| Net Operating Profit after Tax (NOPAT) |
|
76 |
64 |
53 |
-355 |
0.00 |
| NOPAT Margin |
|
0.00% |
0.00% |
2,660.00% |
-4,436.25% |
0.00% |
| Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.00% |
2.50% |
7.39% |
0.00% |
| SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Operating Expenses to Revenue |
|
0.00% |
0.00% |
-3,700.00% |
6,437.50% |
-350.00% |
| Earnings before Interest and Taxes (EBIT) |
|
108 |
92 |
76 |
-507 |
72 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
296 |
285 |
295 |
-293 |
286 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
| Price to Book Value (P/BV) |
|
0.00 |
0.00 |
0.91 |
1.98 |
1.56 |
| Price to Tangible Book Value (P/TBV) |
|
0.00 |
0.00 |
14.89 |
4.09 |
3.27 |
| Price to Revenue (P/Rev) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Price to Earnings (P/E) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Dividend Yield |
|
0.00% |
0.00% |
0.00% |
0.48% |
2.45% |
| Earnings Yield |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Enterprise Value to Invested Capital (EV/IC) |
|
0.00 |
0.00 |
0.97 |
1.55 |
1.31 |
| Enterprise Value to Revenue (EV/Rev) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
0.00 |
0.00 |
0.00 |
40.92 |
| Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
26.54 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
| Debt to Equity |
|
0.00 |
0.00 |
1.85 |
0.50 |
0.55 |
| Long-Term Debt to Equity |
|
0.00 |
0.00 |
1.84 |
0.49 |
0.53 |
| Financial Leverage |
|
0.00 |
0.00 |
1.85 |
0.50 |
0.55 |
| Leverage Ratio |
|
0.00 |
0.00 |
3.26 |
1.90 |
1.95 |
| Compound Leverage Factor |
|
0.00 |
0.00 |
-3.13 |
2.21 |
0.22 |
| Debt to Total Capital |
|
0.00% |
0.00% |
64.91% |
33.46% |
35.54% |
| Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.30% |
0.89% |
1.26% |
| Long-Term Debt to Total Capital |
|
0.00% |
0.00% |
64.60% |
32.57% |
34.28% |
| Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.01% |
0.00% |
0.00% |
| Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
5.34% |
7.20% |
7.08% |
| Common Equity to Total Capital |
|
0.00% |
0.00% |
29.74% |
59.33% |
57.37% |
| Debt to EBITDA |
|
0.00 |
0.00 |
0.00 |
0.00 |
11.13 |
| Net Debt to EBITDA |
|
0.00 |
0.00 |
0.00 |
0.00 |
10.72 |
| Long-Term Debt to EBITDA |
|
0.00 |
0.00 |
0.00 |
0.00 |
10.73 |
| Debt to NOPAT |
|
0.00 |
0.00 |
0.00 |
0.00 |
-18.35 |
| Net Debt to NOPAT |
|
0.00 |
0.00 |
0.00 |
0.00 |
-17.67 |
| Long-Term Debt to NOPAT |
|
0.00 |
0.00 |
0.00 |
0.00 |
-17.70 |
| Noncontrolling Interest Sharing Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
10.99% |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
0.00 |
0.00 |
-16,344 |
-15,568 |
-14,965 |
| Operating Cash Flow to CapEx |
|
0.00% |
129.38% |
0.00% |
121.57% |
92.05% |
| Free Cash Flow to Firm to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating Cash Flow to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating Cash Flow Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
| Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
| Invested Capital |
|
0.00 |
0.00 |
16,397 |
15,213 |
14,965 |
| Invested Capital Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Increase / (Decrease) in Invested Capital |
|
0.00 |
0.00 |
16,397 |
15,213 |
14,965 |
| Enterprise Value (EV) |
|
0.00 |
0.00 |
15,881 |
23,621 |
19,561 |
| Market Capitalization |
|
4,437 |
4,437 |
4,437 |
17,846 |
13,379 |
| Book Value per Share |
|
$0.00 |
$0.00 |
$30.10 |
$39.64 |
$37.63 |
| Tangible Book Value per Share |
|
$0.00 |
$0.00 |
$1.84 |
$19.15 |
$17.93 |
| Total Capital |
|
0.00 |
0.00 |
16,397 |
15,213 |
14,965 |
| Total Debt |
|
0.00 |
0.00 |
10,643 |
5,091 |
5,319 |
| Total Long-Term Debt |
|
0.00 |
0.00 |
10,593 |
4,955 |
5,130 |
| Net Debt |
|
0.00 |
0.00 |
10,567 |
4,679 |
5,122 |
| Capital Expenditures (CapEx) |
|
0.00 |
177 |
0.00 |
153 |
151 |
| Net Nonoperating Expense (NNE) |
|
84 |
114 |
133 |
188 |
0.00 |
| Net Nonoperating Obligations (NNO) |
|
0.00 |
0.00 |
10,643 |
5,091 |
5,319 |
| Total Depreciation and Amortization (D&A) |
|
188 |
193 |
219 |
214 |
214 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
($0.46) |
($2.44) |
$0.01 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
162M |
210M |
228M |
| Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
($0.46) |
($2.44) |
$0.01 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
162M |
210M |
228M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
227.69M |
228.41M |
228.59M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
-854 |
-850 |
-865 |
-869 |
-858 |
| Normalized NOPAT Margin |
|
0.00% |
0.00% |
-43,225.00% |
-10,867.50% |
-5,363.75% |
| Pre Tax Income Margin |
|
0.00% |
0.00% |
-3,650.00% |
-7,350.00% |
50.00% |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
| EBIT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| NOPAT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| NOPAT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Payout Ratios |
|
- |
- |
- |
- |
- |
| Dividend Payout Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
-36.42% |
| Augmented Payout Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
-38.83% |
Key Financial Trends
Lineage, Inc. (NASDAQ: LINE) has shown varied financial performance across recent quarters with some notable trends emerging in their income statement, cash flow, and balance sheet data from Q2 2023 through Q1 2025.
Positive factors:
- Q1 2025 saw significant net realized & unrealized capital gains on investments totaling $16 million, double the $8 million gain posted in Q3 2024, supporting total revenue for the quarter.
- The company maintained positive net cash from operating activities even in Q1 2025 ($139 million), indicating ongoing operational cash generation despite challenging earnings.
- Cash and cash equivalents remain robust at $197 million as of Q1 2025, providing liquidity buffer.
- Lineage's issuance of debt increased in recent quarters (e.g., $582 million in Q1 2025), which may support expansion or refinancing opportunities.
- Depreciation expense has been fairly stable around $150-210 million, reflecting ongoing investment in premises and equipment, a sign of maintaining or growing their asset base.
Neutral factors:
- Total revenue remains relatively low compared to the scale of operating expenses, with $16 million revenue in Q1 2025 versus largely negative operating earnings, showing a disconnect that may need to be reconciled by business model changes or asset sales.
- Weighted average shares outstanding increased from approximately 162 million in mid-2023 to 228 million by early 2025, indicating dilution which could affect earnings per share trends.
- The company recorded negative net income continuing operations for many quarters, but Q1 2025 shows breakeven net income, suggesting some stabilization.
- The effect of exchange rate changes on cash flows has been negligible or zero in recent quarters, indicating limited currency risk currently.
Negative factors:
- Lineage has consistently posted net losses in recent quarters, e.g., -$543 million in Q3 2024, -$80 million in Q4 2024, and essentially breakeven in Q1 2025, signaling ongoing profitability challenges.
- Total non-interest expense remains sizable, with unusual “other special charges” significantly negative (e.g., -$1.29 billion in Q1 2025) indicating one-time or recurring write-downs or costs impacting profitability.
- Restructuring charges remain high (e.g., $15 million in Q1 2025, $592 million in Q3 2024), showing ongoing organizational changes and potential instability.
- Total liabilities have remained high (approximately $9.1 billion as of Q1 2025) compared to total equity ($8.6 billion common equity), reflecting a leveraged balance sheet with ongoing debt repayments exceeding new issuance some quarters.
- The company’s retained earnings are negative (-$1.97 billion as of Q1 2025), signaling accumulated losses that reduce net worth.
- Decreasing cash from investing activities (e.g., -$138 million in Q1 2025) coupled with high capital expenditure signals heavy ongoing investments but pressures cash reserves.
- Payment of dividends remains substantial even during loss-making periods ($134 million paid in Q1 2025), which could constrain cash flow flexibility.
Overall, Lineage shows some signs of stabilizing operational cash flow and occasional investment gains, but it continues to struggle with high expenses, restructuring costs, and negative earnings. The leveraged balance sheet and ongoing capital expenditures imply the company is investing for future growth but must improve profitability for sustainable shareholder value. Investors should watch for improvements in earnings, expense control, and whether operating revenues can grow to offset these pressures.
10/25/25 03:42 PM ETAI Generated. May Contain Errors.